Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 21, 2019 12:32 ET | Source: Sanofi Pasteur

Sanofi UK marketing authorisation granted for Sanofi Pasteur’s Trivalent Influenza Vaccine (Split Virion, Inactivated) High Dose▼(TIV High Dose)

Press Release Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY) UK marketing authorisation granted for Sanofi Pasteur’s Trivalent Influenza Vaccine (Split Virion, Inactivated) High Dose▼(TIV High Dose) ...